Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1035 results for "usfda"

Strides gets USFDA nod for generic anti-anxiety tablets
Business Standard

Strides gets USFDA nod for generic anti-anxiety tablets

Drug firm Strides Arcolab today received approval from the US health regulator for its generic Buspirone Hydrochloride tablets used for treating anxiety disorders. The company has received approval from the United States Food & Drug Administration (USFDA) for ... Business Standard, 1 day ago

35 images for usfda, 1 day ago, 1 week ago
Business Standard India, 1 day ago
Business Standard India, 4 days ago
Financial Express, 2 weeks ago
Business Standard India, 5 days ago
Business Standard, 1 week ago
Bio Spectrum Asia, 2 weeks ago
NDTV Profit, 2 weeks ago
Bio Spectrum Asia, 2 weeks ago
International Business Times India

USFDA issues warns Marck Biosciences for GMP violation

The US drug regulator has issued an import alert for the company's products manufactured at its Kheda unit into the US
 Business Standard5 days ago USFDA issues warning to Indian drug maker Marck Biosciences  Economic Times5 days ago USFDA issues warning to Marck Biosciences  Economic Times5 days ago Indian drug regulator plugs quality gaps after drawing flak from USFDA  Hindu Business Line1 week ago
Business Standard


Marck Biosciences of Gujarat has received a warning letter from the US Food and Drug Administration (USFDA) on its plant at Kheda in Gujarat for alleged violations of current good manufacturing practice (CGMP) regulations for ...
 Pharmaceutical & Medical Packaging News2 days ago Marck Bio "surprised" at USFDA warning over Gujarat plant  Hindu Business Line5 days ago

Expect double-digit growth in FY15: Nectar Life

Dinesh Dua CEO Nectar Lifesciences S The company is hoping to get USFDA approval for its formulations plant in Baddi. Of late, Nectar is focussing on changing revenue mix to formulation instead of APIs. Below is the transcript of Dinesh Dua's ...
 Moneycontrol.com5 days ago Promoters not looking to offload stake: Nectar Lifesciences  Money Control2 months ago

Marck Biosciences plans to re-apply for FDA certification within next one yr

It received warning letter from USFDA for alleged violations of CGMP for finished pharmaceuticals BS Reporter | Ahmedabad August 22, 2014 Last Updated at 16:15 IST Ahmedabad-based Marck Biosciences plans to appoint an external consultant to sort out ...
 Business Standard India5 days ago

Cadila Healthcare jumps after USFDA OK for anti-viral drug

Cadila Healthcare rose 3.67% to Rs 1,235.70 at 12:50 IST on BSE after the company said Zydus Cadila has received the final approval from the US drug regulator to sell anti-viral drug in multiple strengths in the US market. The company made the ...
 Capital Market1 week ago

Sun Pharma unit recalls cephalexin capsules from US: PTI

Recall triggered by a USFDA notification stating that these products were manufactured with APIs that were not manufactured with GMP
 Business Standard1 week ago

Indoco Remedies soars after USFDA nod for Goa facilities

It's earnings season., a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...
 India Infoline1 month ago Indoco Remedies hits record high on USFDA nod for facilities in Goa  Business Standard1 month ago Indoco Remedies at new high, up 20% on USFDA nod for Goa  Money Control1 month ago USFDA nod: Indoco Remedies sees US sales more than double  Money Control1 month ago

Indoco Remedies spurts 14% after USFDA approves Goa plants

 MyIris1 month ago Indoco Remedies rallies 20%, hits 52-week high after USFDA approves plants  Economic Times1 month ago Indoco Remedies up 20% as USFDA approves plants  Economic Times1 month ago USFDA approval to buoy Indoco Remedies  Hindu Business Line1 month ago
Business Standard India

Wockhardt's net profit witnesses steep fall in Q1

The ban by US Food and Drug Administration (USFDA) on Wockhardt's manufacturing plants is taking a toll on its performance with the company reporting a 94% dip in net profit for the quarter ending June 2014, according to a Reuters report. The drug ...
 Business Standard India2 weeks ago Wockhardt Q1 net falls 94% on USFDA plant bans  Business Standard2 weeks ago Wockhardt Q1 net falls 94% as USFDA bans take toll  Smart Investor2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - usfda
Get updated on latest news & your favorite topics right in your inbox!
More     Less